A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients-Reference-Cited by-同舟云学术

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

Published:2017-11-11 Issue:1 Volume:13 Page:69-78
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Alsina Maria^ORCID, ,Rivera Fernando,Ramos Francisco Javier,Galán Maica,López Rafael,García-Alfonso Pilar,Alés-Martinez José Enrique,Queralt Bernardo,Antón Antonio,Carrato Alfredo,Grávalos Cristina,Méndez-Vidal Maria José,López Carlos,de Mena Inmaculada Ruiz,Tabernero Josep,Giralt Jordi,Aranda Enrique

Funder

Merck

Sanofi-Aventis

Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) in collaboration with the Spanish Clinical Research in Oncological Radiotherapy Group (GICOR)

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s11523-017-0536-z/fulltext.html

Reference40 articles.

1. IARC/WHO. GLOBOCAN 2012. Online prediction of estimated cancer incidence. http://globocan.iarc.fr/Pages/burden_sel.aspx . Accessed Jul 2017.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

3. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–7.

4. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086–92.

5. van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074–2084.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18

2. STUDY TO KNOW THE MORTALITY AND MORBIDITY OF CARCINOMA OESOPHAGUS;INDO AM J PHARM SCI;2018

3. Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients;Targeted Oncology;2017-12-14